The Future of Telehealth-Based Psychological and Mind–Body Interventions for People With Inflammatory Bowel Disease: A Systematic Review

Abstract

Objectives: People with inflammatory bowel disease (IBD) suffer from relapsing and remitting symptoms of gastrointestinal upset and are at substantial risk of experiencing comorbid mental distress symptoms. We aimed to conduct a systematic review of the evidence surrounding mental health telehealth interventions for IBD patients.

Methods: We searched EMBASE, MEDLINE, CINAHL, Scopus, and PsychINFO to systematically identify studies that evaluated the feasibility and acceptability of telehealth-based psychological and mind–body interventions to treat the physical and psychosocial symptoms of IBD patients. Predefined data extraction variables included descriptions of the interventions, participation and dropout rates, and preliminary effectiveness. The data was synthesized using tabular data displayed for quantitative variables and presented as narrative summaries to allow for comparison.

Results: Seven studies including 313 participants met our criteria and were included in the review. All studies evaluated distinct interventions. Participation rates ranged 32.4%–75%, and drop-out rates ranged 0%–33%. Most participants reported improvements in their quality of life and mental symptoms, and high satisfaction within their interventions. The authors of all included studies concluded that their interventions were feasible.

Conclusions: The evidence to support using telehealth-based psychological and mind–body interventions to support individuals with IBD is limited, but promising. Interventions were positively evaluated, strongly adhered to, and preliminary effectiveness data suggest that these interventions could improve the psychosocial well-being of people with IBD. Future research is warranted to assess the effectiveness of these interventions and to evaluate the barriers to integrating them into IBD care.

Keywords

feasibility / inflammatory bowel diseases / mental health / psychiatric care / systematic review

References

[1] M. Fakhoury, R. Negrulj, A. Mooranian, and H. Al-Salami, “Inflammatory Bowel Disease: Clinical Aspects and Treatments,” Journal of Inflammation Research 7 (2014): 113-120.

[2] C. S. Tse, C. H. Weng, M. Kwon, et al., “Increased Risks for Suicide, Self-Harm, Substance Use, and Psychiatric Disorders in Adults With Inflammatory Bowel Disease: A Nationwide Study in the United States From 2007 to 2017,” Inflammatory Bowel Diseases 30, no. 1 (2024): 150-153.

[3] S. R. Knowles, L. Keefer, H. Wilding, C. Hewitt, L. A. Graff, and A. Mikocka-Walus, “Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-Analyses—Part II,” Inflammatory Bowel Diseases 24, no. 5 (2018): 966-976.

[4] R. L. Keeton, A. Mikocka-Walus, and J. M. Andrews, “Concerns and Worries in People Living With Inflammatory Bowel Disease (IBD): A Mixed Methods Study,” Journal of Psychosomatic Research 78, no. 6 (2015): 573-578.

[5] K. M. Fairbrass, D. J. Gracie, and A. C. Ford, “Longitudinal Follow-Up Study: Effect of Psychological Co-Morbidity on the Prognosis of Inflammatory Bowel Disease,” Alimentary Pharmacology & Therapeutics 54, no. 4 (2021): 441-450.

[6] K. M. Fairbrass, J. Lovatt, B. Barberio, Y. Yuan, D. J. Gracie, and A. C. Ford, “Bidirectional Brain-Gut Axis Effects Influence Mood and Prognosis in IBD: A Systematic Review and Meta-Analysis,” Gut 71, no. 9 (2022): 1773-1780.

[7] A. Dignass, G. Van Assche, J. O. Lindsay, et al., “The Second European Evidence-Based Consensus on the Diagnosis and Management of Crohn's Disease: Current Management,” Journal of Crohn's and Colitis 4, no. 1 (2010): 28-62.

[8] A. Dignass, J. O. Lindsay, A. Sturm, et al., “Second European Evidence-Based Consensus on the Diagnosis and Management of Ulcerative Colitis Part 2: Current Management,” Journal of Crohn's and Colitis 6, no. 10 (2012): 991-1030.

[9] L. Keefer, S. K. Ballou, D. A. Drossman, G. Ringstrom, S. Elsenbruch, and B. Ljótsson, “A Rome Working Team Report on Brain-Gut Behavior Therapies for Disorders of Gut-Brain Interaction,” Gastroenterology 162, no. 1 (2022): 300-315.

[10] C. Naude, D. Skvarc, S. Knowles, L. Russell, S. Evans, and A. Mikocka-Walus, “The Effectiveness of Mindfulness-Based Interventions in Inflammatory Bowel Disease: A Systematic Review & Meta-Analysis,” Journal of Psychosomatic Research 169 (2023): 111232, https://doi.org/10.1016/j.jpsychores.2023.111232.

[11] T. Ewais, J. Begun, M. Kenny, et al., “A Systematic Review and Meta-Analysis of Mindfulness Based Interventions and Yoga in Inflammatory Bowel Disease,” Journal of Psychosomatic Research 116 (2019): 44-53.

[12] C. Riggott, A. Mikocka-Walus, D. J. Gracie, and A. C. Ford, “Efficacy of Psychological Therapies in People With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis,” Lancet Gastroenterology & Hepatology 8, no. 10 (2023): 919-931.

[13] R. Lawrence and C. Choudhary, “Barriers to Psychosocial Support and Quality of Life for Patients With Inflammatory Bowel Disease: A Survey Study,” Crohn's & Colitis 360 2, no. 4 (2020): otaa068, https://doi.org/10.1093/crocol/otaa068.

[14] S. T. Syed, B. S. Gerber, and L. K. Sharp, “Traveling Towards Disease: Transportation Barriers to Health Care Access,” Journal of Community Health 38, no. 5 (2013): 976-993.

[15] I. Hanlon, C. Hewitt, K. Bell, A. Phillips, and A. Mikocka-Walus, “Systematic Review With Meta-Analysis: Online Psychological Interventions for Mental and Physical Health Outcomes in Gastrointestinal Disorders Including Irritable Bowel Syndrome and Inflammatory Bowel Disease,” Alimentary Pharmacology & Therapeutics 48, no. 3 (2018): 244-259.

[16] H. Greenwood, N. Krzyzaniak, R. Peiris, et al., “Telehealth Versus Face-To-Face Psychotherapy for Less Common Mental Health Conditions: Systematic Review and Meta-Analysis of Randomized Controlled Trials,” JMIR Mental Health 9, no. 3 (2022): e31780, https://doi.org/10.2196/31780.

[17] N. Alavi, E. Moghimi, C. Stephenson, et al., “Comparison of Online and In-Person Cognitive Behavioral Therapy in Individuals Diagnosed With Major Depressive Disorder: A Non-Randomized Controlled Trial,” Frontiers in Psychiatry 14 (2023): 1113956, https://doi.org/10.3389/fpsyt.2023.1113956.

[18] H. Steiger, L. Booij, O. Crescenzi, et al., “In-Person Versus Virtual Therapy in Outpatient Eating-Disorder Treatment: A COVID-19 Inspired Study,” International Journal of Eating Disorders 55, no. 1 (2022): 145-150.

[19] S. M. Eldridge, G. A. Lancaster, M. J. Campbell, et al., “Defining Feasibility and Pilot Studies in Preparation for Randomised Controlled Trials: Development of a Conceptual Framework,” PLoS One 11, no. 3 (2016): e0150205, https://doi.org/10.1371/journal.pone.0150205.

[20] S. M. Eldridge, C. L. Chan, M. J. Campbell, et al., “CONSORT 2010 Statement: Extension to Randomised Pilot and Feasibility Trials,” BMJ 355 (2016): i5239, https://doi.org/10.1136/bmj.i5239.

[21] T. Weldring and S. M. S. Smith, “Patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs),” Health Services Insights 6 (2013): 61-68.

[22] J. A. Sacristán, “Patient-Centered Medicine and Patient-Oriented Research: Improving Health Outcomes for Individual Patients,” BMC Medical Informatics and Decision Making 13 (2013): 6, https://doi.org/10.1186/1472-6947-13-6.

[23] M. J. Page, J. E. McKenzie, P. M. Bossuyt, et al., “The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews,” PLoS Medicine 18, no. 3 (2021): e1003583, https://doi.org/10.1371/journal.pmed.1003583.

[24] M. J. Page, D. Moher, P. M. Bossuyt, et al., “PRISMA 2020 Explanation and Elaboration: Updated Guidance and Exemplars for Reporting Systematic Reviews,” BMJ 372 (2021): n160, https://doi.org/10.1136/bmj.n160.

[25] Veritas Health Innovation, Covidence Systematic Review Software [Internet] (Veritas Health Innovation, 2023), www.covidence.org.

[26] D. J. Bowen, M. Kreuter, B. Spring, et al., “How we Design Feasibility Studies,” American Journal of Preventive Medicine 36, no. 5 (2009): 452-457.

[27] National Heart, Lung, and Blood Institute, “Study Quality Assessment Tools,”2024, https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools.

[28] R. L. Wasserstein and N. A. Lazar, “The ASA's Statement on p-Values: Context, Process, and Purpose,” American Statistician 70, no. 2 (2016): 129-133.

[29] M. A. Hernán and S. Hernández-Díaz, “Beyond the Intention-to-Treat in Comparative Effectiveness Research,” Clinical Trials 9, no. 1 (2012): 48-55.

[30] M. A. Hernán, S. Hernández-Díaz, and J. M. Robins, “Randomized Trials Analyzed as Observational Studies,” Annals of Internal Medicine 159, no. 8 (2013): 560-562.

[31] M. Artom, W. Czuber-Dochan, J. Sturt, H. Proudfoot, D. Roberts, and C. Norton, “Cognitive-Behavioural Therapy for the Management of Inflammatory Bowel Disease-Fatigue: A Feasibility Randomised Controlled Trial,” Pilot and Feasibility Studies 5 (2019): 145, https://doi.org/10.1186/s40814-019-0538-y.

[32] M. Mascarenhas, S. Vellanki, A. Boateng, et al., “Live Video Mindfulness Program is a Safe, Feasible, and Acceptable Intervention for Youth with Inflammatory Bowel Disease,” Global Advances in Health and Medicine 11, no. Suppl 1 (2022): 59-60.

[33] T. Lores, S. Evans, A. Chur-Hansen, et al., “Virtual Adjunctive Gut-Directed Hypnotherapy for People With Crohn's Disease: A Randomized Controlled Pilot and Feasibility Trial,” Complementary Therapies in Clinical Practice 53 (2023): 101791, https://doi.org/10.1016/j.ctcp.2023.101791.

[34] K. A. Hommel, E. Hente, M. Herzer, L. M. Ingerski, and L. A. Denson, “Telehealth Behavioral Treatment for Medication Nonadherence: A Pilot and Feasibility Study,” European Journal of Gastroenterology and Hepatology 25, no. 4 (2013): 469-473.

[35] G. Goren, D. Schwartz, M. Friger, et al., “Randomized Controlled Trial of Cognitive-Behavioral and Mindfulness-Based Stress Reduction on the Quality of Life of Patients With Crohn Disease,” Inflammatory Bowel Diseases 28, no. 3 (2022): 393-408.

[36] D. Romano, S. Chesterman, M. Fuller-Tyszkiewicz, et al., “Feasibility, Acceptability, and Preliminary Efficacy of Acceptance Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress,” Inflammatory Bowel Diseases 30, no. 6 (2024): 911-921.

[37] J. Lavelle, D. Storan, V. Eswara Murthy, N. De Dominicis, H. E. Mulcahy, and L. McHugh, “Brief and Telehealth Acceptance and Commitment Therapy (ACT) Interventions for Stress in Inflammatory Bowel Disease (IBD): A Series of Single Case Experimental Design (SCED) Studies,” Journal of Clinical Medicine 11, no. 10 (2022): 2757, https://doi.org/10.3390/jcm11102757.

[38] J. Shaver, “The State of Telehealth Before and After the COVID-19 Pandemic,” Primary Care: Clinics in Office Practice 49, no. 4 (2022): 517-530.

[39] M. Shanyinde, R. M. Pickering, and M. Weatherall, “Questions Asked and Answered in Pilot and Feasibility Randomized Controlled Trials,” BMC Medical Research Methodology 11 (2011): 117, https://doi.org/10.1186/1471-2288-11-117.

[40] F. Baekeland and L. Lundwall, “Dropping out of Treatment: A Critical Review,” Psychological Bulletin 82, no. 5 (1975): 738-783.

[41] J. Long, K. Sakauye, K. Chisty, and J. Upton, “The Empty Chair Appointment,” SAGE Open 6, no. 1 (2016): 2158244015625094, https://doi.org/10.1177/2158244015625094.

[42] P. R. Deshpande, S. Rajan, B. L. Sudeepthi, and C. P. A. Nazir, “Patient-Reported Outcomes: A New Era in Clinical Research,” Perspectives in Clinical Research 2, no. 4 (2011): 137-144.

[43] M. C. Wang, D. Mosen, E. Shuster, and J. Bellows, “Association of Patient-Reported Care Coordination With Patient Satisfaction,” Journal of Ambulatory Care Management 38, no. 1 (2015): 69-76.

[44] Q. Chen, E. W. Beal, V. Okunrintemi, et al., “The Association Between Patient Satisfaction and Patient-Reported Health Outcomes,” Journal of Patient Experience 6, no. 3 (2019): 201-209.

[45] M. Faezipour and S. Ferreira, “A System Dynamics Perspective of Patient Satisfaction in Healthcare,” Procedia Computer Science 16 (2013): 148-156.

[46] B. Bajgain, S. Rabi, S. Ahmed, V. Kiryanova, P. Fairie, and M. J. Santana, “Patient-Reported Experiences and Outcomes of Virtual Care During COVID-19: A Systematic Review,” Journal of Patient-Reported Outcomes 7, no. 1 (2023): 126, https://doi.org/10.1186/s41687-023-00659-8.

[47] B. Thibaut, L. H. Dewa, S. C. Ramtale, et al., “Patient Safety in Inpatient Mental Health Settings: A Systematic Review,” BMJ Open 9, no. 12 (2019): e030230, https://doi.org/10.1136/bmjopen-2019-030230.

[48] K. Bennett, A. J. Bennett, and K. M. Griffiths, “Security Considerations for E-Mental Health Interventions,” Journal of Medical Internet Research 12, no. 5 (2010): e61, https://doi.org/10.2196/jmir.1468.

RIGHTS & PERMISSIONS

2025 The Author(s). Journal of Digestive Diseases published by Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.